Table 1.
Basic patient characteristics and efficacy.
| Characteristic | Number |
|---|---|
| Age (year) | |
| <50 year | 61 (55.50%) |
| ≥50 year | 49 (44.50%) |
| FIGO stage | |
| I | 14 (12.70%) |
| II | 38 (34.50%) |
| III | 53 (48.30%) |
| IV | 5 (4.50%) |
| Histological type | |
| SCC | 97 (88.20%) |
| Non-SCC | 13 (11.80%) |
| Lymph node metastasis | |
| Negative | 57 (51.80%) |
| Positive | 53 (48.20%) |
| Maximum tumour size (cm) | |
| >4 cm | 65 (59.10%) |
| ≤4 cm | 45 (40.90%) |
| Prognosis | |
| Effective | 73 (66.40%) |
| Ineffective | 37 (33.60%) |
FIGO, International Federation of Gynaecology and Obstetrics; SCC, squamous cell carcinoma.